We’re Evolving—Immortality.global 2.0 is Incubating
The platform is in maintenance while we finalize a release that blends AI and longevity science like never before.

www.psychologytoday.com


A UCLA-led team demonstrates a shared-autonomy framework integrating a convolutional neural network–Kalman filter (CNN-KF) with AI copilots to decode EEG signals from a noninvasive 64-channel cap. This approach amplifies task-directed cursor and robotic arm control, yielding a 3.9× performance boost for a paraplegic participant. The system leverages closed-loop decoder updates and environment-aware action distributions, offering a nonoperative BCI solution with improved accuracy for motor-impaired individuals.

Key points

  • Combines convolutional neural network and Kalman filter (CNN-KF) to decode noisy EEG signals.
  • Implements shared-autonomy AI copilot for real-time closed-loop decoder updates and environment-aware action distributions.
  • Demonstrates 3.9× performance improvement in cursor and robotic arm control for a paraplegic participant using noninvasive EEG.

Why it matters: This AI-driven noninvasive BCI paradigm promises to overcome EEG limitations, offering scalable, high-accuracy neural control for assistive neurotechnology.

Q&A

  • What is a convolutional neural network–Kalman filter?
  • How do invasive and noninvasive BCIs differ?
  • What is shared autonomy in BCIs?
  • What are the main challenges in noninvasive BCI adoption?
Copy link
Facebook X LinkedIn WhatsApp
Share post via...
AI Copilot Boosts Brain-Computer Interface's Performance

Anjan Chatterjee MD, FAAN, of the University of Pennsylvania surveys recent breakthroughs in longevity science, including epigenetic modulation, gene editing, cellular senescence reprogramming, stem-cell regeneration, and pharmacological interventions like metformin and rapamycin. The article also critically evaluates potential socioeconomic inequities, geopolitical consequences, and the distinction between lifespan extension and eudaimonic well-being.

Key points

  • Epigenetic modifications: CRISPR and small-molecule epigenetic modulators reverse age-related chromatin changes in rodent and human cell assays, improving genomic stability metrics.
  • Senolytics and reprogramming: Rapamycin and metformin treatments in aged mice clear senescent cells and restore tissue function, measured by mobility and organ-specific biomarkers.
  • Stem-cell regeneration: Autologous stem-cell transplants and young plasma factors enhance regenerative capacity in preclinical models, quantified by increased tissue repair rates and reduced inflammatory markers.

Why it matters: Prioritizing lifespan extension without addressing ethical, economic, and quality-of-life dimensions risks exacerbating inequities and undermining genuine human flourishing.

Q&A

  • What mechanisms drive biological aging?
  • How do metformin and rapamycin slow aging?
  • What are the main ethical concerns in lifespan extension?
  • What distinguishes eudaimonia from longevity?
Copy link
Facebook X LinkedIn WhatsApp
Share post via...
The Long and Short of Longevity: Why More Might Be Less

A 2022 study by Eric S. Kim highlights that a strong purpose reduces mortality by 46% and enhances cognitive function. In his Psychology Today piece, Ali Mostashari, Ph.D. demonstrates that purpose planning is vital for sustained wellness and active living.

Q&A

  • What is life purpose?
  • How does purpose affect longevity?
Copy link
Facebook X LinkedIn WhatsApp
Share post via...
The Hidden Power of Purpose for Longevity